Fundraising FoxEcho Therapeutics
Iselin, US · Delaware corporation
Find your way into Echo Therapeutics
Sign up to see every warm intro you have to Echo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Echo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SW
Scott W. HollanderExecutive
AS
Alan SchoenbartExecutive
Board
MM
Michael M. GoldbergBoard director
ER
Elazer R. EdelmanBoard director
SG
Shepard GoldbergBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2016
▶$1.8MraisedFeb 2016 · 15 investors · BiotechnologyRule 506(b)
▶$1.8MraisedFeb 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott W. HollanderExecutive Officer, Director
- Alan SchoenbartExecutive Officer
- Michael M. GoldbergDirector
- Elazer R. EdelmanDirector
- Shepard GoldbergDirector
- Offering amount
- $6M
- Amount sold
- $1.8M
- Minimum investment
- $50K
- Sales commissions
- $145.5K
- Proceeds to insiders
- $200K
- Placement agents
- Newbridge Securities Corporation
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Echo Therapeutics raised?
- Echo Therapeutics has disclosed $1.8M raised across 1 round.
- Where is Echo Therapeutics headquartered?
- Echo Therapeutics is headquartered in Iselin, US.